MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字H20244528

July 30, 2024

Drug Information

利伐沙班片

片剂

2.5mg

化学药品

July 30, 2024

Company Information

Applicant Company

安徽省合肥市高新区柏堰湾路2600号

Manufacturing Company

浙江省宁波市北仑区大榭街道滨海西路85号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.